Study: For Treating Retinopathy of Prematurity, UB-Led Research Proves That Ranibizumab is Safe
May 11, 2024
May 11, 2024
BUFFALO, New York, May 11 (TNSres) -- The University at Buffalo (State University of New York) issued the following news release:
A University at Buffalo researcher who is a leading expert on retinopathy of prematurity (ROP) has published a study that could change the standard of care for the condition. ROP occurs in low birthweight premature babies; if not treated, it can lead to blindness.
The study, published in eClinicalMedicine online before print on April 11, answ . . .
A University at Buffalo researcher who is a leading expert on retinopathy of prematurity (ROP) has published a study that could change the standard of care for the condition. ROP occurs in low birthweight premature babies; if not treated, it can lead to blindness.
The study, published in eClinicalMedicine online before print on April 11, answ . . .
